Online supplementary material - Measurement of tralokinumab concentrations in serum and tear fluid of atopic dermatitis patients and the relationship with treatment response and ocular surface disease

- Detailed description of the successful development and validation of the LC-MS/MS method for measuring tralokinumab concentrations in in serum and tear fluid - Baseline characteristics

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-02
DOI
https://doi.org/10.5281/zenodo.15576665
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Online supplementary material - Measurement of tralokinumab concentrations in serum and tear fluid of atopic dermatitis patients and the relationship with treatment response and ocular surface disease

Zenodo (CERN European Organization for Nuclear Research)
Dermatology and Skin Diseases
article

Online supplementary material - Measurement of tralokinumab concentrations in serum and tear fluid of atopic dermatitis patients and the relationship with treatment response and ocular surface disease

article en

Abstract

- Detailed description of the successful development and validation of the LC-MS/MS method for measuring tralokinumab concentrations in in serum and tear fluid - Baseline characteristics

Zenodo (CERN European Organization for Nuclear Research)
University Medical Center Utrecht (NL)
Openalex Percentile: Top 34%
Dermatology and Skin Diseases
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Online supplementary material - Measurement of tralokinumab concentrations in serum and tear fluid of atopic dermatitis patients and the relationship with treatment response and ocular surface disease · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS